Sell signal, week 2 · US stocks
Phio slips 2.5% as daily resistances turn price back toward its 30-day low
Our view last week
After 10 weeks above zero, money flow on Phio Pharmaceuticals stock has turned negative, and the week closes at -1.9%. The weekly price action shows sellers ahead and a distribution phase underway: the buyers who returned a week ago have already given ground, and a fresh sell signal fires. Price stays boxed between the 0.99 area and the 1.02 area, below the Kumo. A technical analysis of one of the US stocks where trading is not recommended.
This week's summary
The climb finds no way through: the band of daily resistances between the 1.02 area and the 1.06 area turned price back again, and the week closes down 2.5%. Phio Pharmaceuticals stock stays below the Kumo, with money flow negative for a 2nd straight week after the Sell signal that fired 7 days ago. A technical analysis of a highly volatile name among US stocks, where trading remains not recommended.
IQS Phase
74
in tension
Signal Strength
36
downtrend making lower lows, pace holding
Sizing
REDUCED
Ranking
#71 / 175
US stocks sell signals
Trade P&L %
+2.47%
from signal to date, no stop loss
Phio Pharmaceuticals (PHIO) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 71st among the 175 sell signals for US stocks in our ranking, with a signal strength of 36 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
PHIO belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content